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Cell Biology
RAG-1 interacts with the repeated amino acid motif of the human
homologue of the yeast protein SRP1
[V(D)J recomblon/nudear envdepe]
PATRICIA CORTES, ZHENG-SHENG YE, AND DAVID BALTIMORE
The Rockefelier University, 1230 York Avenue, New York, NY 10021
Contributed by David Baltimore, April 14, 1994
ABSTRACT Genes for immunoglobulins and T-ceil recep-
tor are generated by a process known as V(D)J recombination.
This process is highly regulated and mediated by the recom-
binatlon activating proteins RAG-1 and RAG-2. By the use of
the two-hybrid protein interaction system, we isolated a human
protein that specifically interacts with RAG-i. This protein is
the human homologue of the yeast SRP1 (suppressor of a
temperature-sensitive RNA polymerase I mutation). The
SRP1-1 mutation is an afele-specific dominant sppresor of a
temperature-sensitive mutation in the zinc binding domain of
the 190-kDa subunit of Saccharomyces cerevisiM RNA poly-
merase I. The human SRP cDNA done was used to screen a
mouse cDNA library. We obtained a 3.9-kbp cDNA done
encoding the mouse SRPi. The open reading frame of this
cDNA encodes a 538-amino acid protein with eight degenerate
repeats of 40-45 amino acids each. The mouse and human
SRP1 are 98% identical, whie the mouse and yeast SRP1 have
48% identity. After cotranection of the genes en ing
RAG-i and human SRP1 Into 293T cells, a stable complex was
evident. Deletion analysis indicted that the region of the SRP1
protein interain with RAG-1 involved four repeats. The
domain of RAG-1 that odate with SRP1 mappd N-termi-
nal to the zinc finger domain. Bause this region of RAG-i is
not required for recombination and SRP1 appears to be bound
to the nuclear envelope, we suggest that this iectin helps
to localize RAG-i.
Immunoglobulin and T-cell receptor genes are composed of
different gene segments, present in multiple copies in germ-
line DNA. During development of B and T lymphocytes,
these gene segments are assembled by a mechanism known
as V(D)J (variable-diversity-joining region) recombination.
This recombination process, which is ordered and highly
regulated, leads to the formation of a complete functional
gene. The DNA sequence requirements for V(D)J recombi-
nation are well-characterized. Gene segments are flanked by
highly conserved heptamer and nonamer DNA motifs, sep-
arated from each other by a spacer of 12 or 23 bp (1). These
signal sequences are necessary and sufficient to direct V(D)J
recombination ofexogenous substrates (2-4). However, little
is known about the proteins involved in V(D)J recombina-
tion. Several activities are thought to be components of the
recombinase machinery such as DNA binding, endonucleo-
lytic cleavage, and ligase.
By a genetic approach, two genes known as RAG-1 and
RAG-2 were identified by their ability to activate V(D)J
recombination when cotransfected into fibroblasts that nor-
mally are inactive for recombination (5-7). RAG-1 and
RAG-2 genes are highly conserved between species and their
fundamental role in recombination was demonstrated by the
lack ofB and T cells in RAG-1 and RAG-2 "knockout" mice
(8, 9). Several additional proteins that recognize the heptamer
or nonamer motifs have been identified, but their role in
V(D)J recombination has not yet been proven (10). Recently,
it has become evident that ubiquitously expressed cellular
proteins may be recruited by specific factors to participate in
V(D)J recombination. For example, the gene affected by the
severe combined immune deficient (scid) mutations (11) and
genes involved in double-strand DNA break repair seem to
play an important role during V(D)J recombination (12-14).
We have used the yeast two-hybrid system (15) to identify
proteins that interact with RAG-1. One of these corresponds
to the human homologue ofthe yeast protein SRP1. This gene
was previously cloned from yeast by the ability of a mutant
allele to suppress a mutation of RNA polymerase I. Yeast
SRP1 contains a central region with eight degenerate 42-
amino acid repeats (16). The human homologue has a similar
structure, with eight repeats in the central region of the
protein. This 42-amino acid motif, known as an arm motif,
was first identified in the Drosophila segment polarity gene
armadillo (17) and recently has been found in several proteins
that have diverse cellular functions (18).
Here we describe the human (h) and mouse (m) homo-
logues of SRP1, we show their interaction with RAG-1 in
yeast as well as in mammalian cells, and we map the regions
responsible for the interaction in both proteins. The possible
role of SRP1 in V(D)J recombination is discussed.
MATERIALS AND METHODS
Cels and Antibodies. 293T cells (19) were grown in Dul-
becco's modified Eagle's medium containing 10o fetal bo-
vine serum, penicillin, and streptomycin. Anti-influenza he-
magglutinin (HA) monoclonal antibody (12CA-5) was from
Berkeley antibody company. Anti-glutathione S-transferase
(GST) antibodies were generated in rabbits and affinity
purified. pcDNAI/amp (Invitrogen), p65/GST, and p50-HA
expression vectors will be described elsewhere.
DNA Constructs. A pEG202RAG-1 vector encoding full-
length RAG-1 was assembled from a BamHI/EcoRV PCR
product, an EcoRV/Not I fragment from RAG-1/CDM8, and
a Not I/BamHI pEG202 vector (15). Ligation of these three
fiagments generated pEG202/RAG-1. The joining segments
were sequenced and the expression of the fusion product
RAG-1-LexA was tested by transformation in yeast followed
by Western blotting. pEG202/RAG-1 was used to screen a
human cDNA library. All the subcloning of RAG-1 and
hSRP1 homologue was done by production of in-frame PCR
firgments or by directly subcloning from the cDNA with
short oligonucleotides to leave the protein in-frame. Thejunctions of all constructs were sequenced.
For immunoprecipitation experiments, pcDNAI/amp (In-
vitrogen) was modified by introducing an oligonucleotide
containing an initiation codon in-frame with the HA epitope
Abbreviations: GST, glutathione S-transferase; V(D)J, variable-
diversity-joining region; h-, human; in-, mouse; HA, hemagglutinin;
NLS, nuclear localization signal.
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and a nuclear localization signal (NLS). EcoRI/Xho I sites
were present downstream of the NLS to allow for in-frame
subcloning of the EcoRI/Xho I fragments from the yeast
library vector pJG4-5. RAG-1-GST fusion protein was pro-
duced by subcloning RAG-1 into pEBG1, a modified form of
the vector pEF-BOS (20). The vector pEBG1RAG-1 allows
expression of GST fusion proteins by in-frame subcloning
into BamHI/Not I sites. RAG-1 was also assembled in this
vector by a three part ligation, an in-frame BamHI/EcoRV
PCR product, and an EcoRV/Not I fragment from the
RAG-1/CDM8 vector.
Two-Hybrid Screening. Screening by the two-hybrid system
was performed as described (15, 21). Sequencing of the
interacting clones was performed with Sequenase according to
the manufacturer's directions (United States Biochemical).
Transfections. 293T cells were seeded at a density of 106
cells per 100-mm dish and grown for 1 day before transfec-
tion. Cells were transfected with calcium phosphate as de-
scribed (19). Briefly, each dish was treated with 1 ml of a
DNA calcium phosphate precipitate containing 10 jig of each
plasmid DNA. After incubation at 370C for 24 hr, the medium
was replaced and cells were harvested 48 hr posttransfection.
Immunoprecipitation. 293T cells were metabolically la-
beled with [35S]methionine for 4 hr. Cells were harvested
from the plate and pelleted at 1000 X g for 7 min. Supernatant
was removed and cells were resuspended in 1 ml of RSB (10
mM Tris'HCl, pH 7.4/10 mM NaCl/5 mM MgCl2/0.5%
Nonidet P-40/protease inhibitors). Lysates were incubated
on ice and centrifuged at 1000 x g for 10 min. The cytosolic
fraction was removed and the pellet of nucleus was resus-
pended in 1 ml of LSB (20 mM Tris-HCl, pH 7.4/1 M
NaCl/0.2 mM MgCl2/0.1% Nonidet P-40/protease inhibi-
tors), incubated on ice for 20 min, and spun at 90,000 rpm for
10 min in a Beckman Optima TLX ultracentrifuge. The
supernatant was used for immunoprecipitation. Preimmune
rabbit serum together with 5 gg ofRNase and 10 jg ofDNase
were added to the 1 M extract and incubated for 2 hr. Protein
A-agarose (Boehringer) (40 ,ul) was then added for 1 hr and
centrifuged. The supernatant was used for immunoprecipi-
tation. Either 0.5 ,ug of rabbit polyclonal affinity-purified
GST antibodies or 1.0 jig of monoclonal HA antibody was
added to the precleared extracts and incubated for 2 hr;
protein G-agarose (Boehringer) was then added. Incubation
was continued for 1 hr; beads were recovered by low-speed
centrifugation and washed six times. Immunoprecipitates
were resuspended in SDS loading buffer and samples were
run in a 12.5% polyacrylamide gel and visualized by autora-
diography.
RESULTS
Isolation of Proteins Interacting with RAG-1. The yeast
two-hybrid system as modified by Brent and colleagues (15,
21) was used to identify proteins encoded in aHeLa cell library
that interact with RAG-1. Five million transformants were
screened and 500 potential positives from galactose/Leu-
plates were patched onto galactose 5-bromo-4-chloro-3-
indolyl ,B3D-galactoside plates where colonies producing 3-ga-
lactosidase turn blue. Eighteen blue colonies were further
analyzed. To confirm the interaction between the HeLa cell
protein with RAG-1 and not with LexA, the library plasmid
was recovered from yeast DNA by transformation of the
bacterial strain KC8 (15). DNA prepared from KC8 was used
for sequencing and restriction analysis. The library plasmids
were reintroduced with a reporter into yeast along with a
plasmid expressing either LexA-RAG-1 orjust LexA. The 18
positive clones were found to interact with the LexA-RAG-1
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FIG. 1. Sequence and comparison of hSRPI. rnSRPI. and yeast
SRPl. (A) Alignment of the amino acid sequences. AAmino acids
conserved in yeast SRP1 and mSRP1 are shown in stippled boxe,.
Below the mouse sequence is indicated any amnino acid in the human
sequence that differs from that of the mouse. Asterisk indicates the
beginning of the partial hSRPI clone isolated with the yeast two-
hybrid system. Arrows indicate beginning and end of the different
repeats of SRPI. (B) Expression of hSRP1 and mSRPl. Nuclear
extracts from 293T cells transfected with the indicated cDNAs were
separated by electrophoresis through a SDS/12. 517 polyacrylamnide
gel and Western blotted with antibody raised against the partial
hSRP1. The hSRP1 cDNA was subcloned into pcDNAI' HAn
(hSRP1) and the mSRP1 cDNA into the pcDNAI (mnSRP1). The
control extract was transfected with an empty pcDNAI (controlb.
Arrows indicate proteins immunoreactive with the hSRPliantibod-
ies. Numbers on left are kDa.
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FIG. 2. Interaction of RAG-1 and hSRP1 in mammalian cells. 293T cells transfected with the indicated DNAs were metabolically labeled
with [35S]methionine and nuclear protein extracts were immunoprecipitated with the antibodies indicated at top of the figure, fractionated by
SDS/PAGE, and visualized by autoradiography. (Left) Nuclear extracts from cells transfected with RAG-1-GST and either control plasmid
vector-HA (lanes 1 and 4), hSRP1-HA (lanes 2 and 5), or p50-HA (lanes 3 and 6). (Right) Nuclear extracts from cells transfected with p65/GST
and empty vector-HA (lanes 7 and 10), hSRP1-HA (lanes 8 and 11), or p50-HA (lanes 9 and 12). Arrows identify immunoprecipitated proteins.
Migration of molecular mass markers (kDa) is also indicated. GST-Ab, anti-GST antibodies; HA-Ab, anti-HA antibodies.
fusion but not with LexA alone. Dot blot analysis indicated
that these 18 clones represented 10 different genes. These
genes were subcloned into pcDNA/HAn, a eukaryotic ex-
pression vector under the direction of a cytomegalovirus
promoter. This vector was modified to express fusion proteins
tagged with the influenza virus HA epitope and containing the
NLS from simian virus 40 large tumor antigen. The 10 inde-
pendent cDNAs were cotransfected together with RAG-1-
GST into 293T cells, and the interaction of their protein
products was analyzed by coimmunoprecipitation with anti-
bodies against the HA epitope. Two of the 10 clones specifi-
cally interacted with RAG-1 under the conditions used during
the immunoprecipitation (data not shown).
The Human HIomoogne ofYeast SRP1 Is One ofthe Proteins
That Interact with RAG-i. Sequence analysis of the clones
interacting with RAG-1 revealed that one of them corre-
sponded to the human homologue of the yeast nuclear
envelope protein SRP1 (16). The hSRP1 cDNA (2.8 kbp)
isolated from the HeLa library encoded a 489-amino acid
truncated protein (Fig. 1A). This partial human cDNA was
used to isolate a 3.9-kbp DNA from a mouse cDNA library
(22D6). The sequence analysis of the mouse cDNA showed
an open reading frame encoding a protein of 538 amino acids
(Fig. 1A), with a predicted molecular mass of 60 kDa. The
mouse 3.9-kbp Not I fragment was cloned into the Not I site
of pcDNA I/AMP, a eukaryotic expression vector. Trans-
fection into 293T cells of the vector containing the 3.9-kbp
fiagment in the correct orientation yielded a protein with an
apparent molecular mass of w60 kDa, as determined by
Western blotting with rabbit polyclonal antibodies produced
against a fusion protein containing the 489 amino acids of the
hSRP1 (Fig. iB).
Transfection of the full-length mSRP1 cDNA had no effect
on V(D)J recombination when cotransfected with RAG-1,
RAG-2, and pJH288 in 293T, scid, and xrs-6 cells (data not
shown). The tissue distribution of mSRP1 transcripts was
examined by Northern blot. All mouse tissues analyzed
expressed equivalent levels of SRP1 and two mSRP1 mRNA
species of 4.0 and -5.0 kb were consistently observed (data
not shown).
RAG-1 Associates with hSRP1 in Cels. The
above studies showed that RAG-1 interacted with hSRP1
when expressed in yeast. We next investigated whether
RAG-1 and hSRP1 could interact in mammalian cells. ADNA
construct expressing a RAG-1-GST fusion protein was co-
transfected into 293T cells with plasmid DNA encoding the
489-amino acid, truncated hSRP1 tagged with the HA epitope,
and aNLS under the direction ofa cytomegalovirus promoter.
As controls, we used empty vectors or constructs expressing
the known interacting proteins NF-KB p5 and p65 tagged with
HA orGST, respectively. We cotransfected a vector encoding
RAG-1 or p65 with vectors encoding hSRP1 or p50. Forty-
eight hours after transfection, cells were metabolically labeled
with [35S]methionine for 4-5 hr and nuclear extracts were
prepared and used in immunoprecipitation reactions (see
Materials and Methods; Fig. 2). Anti-GST antibody immuno
precipitated hSRP1-HA when this protein was coexpressed
with RAG-1-GST (lane 2) but not when coexpressed with
p65/GST (lane 8). Conversely, HA antibodies immunoprecip
itated RAG-1-GST when cotransfected with hSRPi-HA (lane
5), but not when cotransfected with the unrelated protein
p50-HA (lane 6). Under similar conditions, the controlp50-HA
and p65/GST formed a very stable complex with each other;
GST antibody coimmunoprecipitated p65/GST together with
p50-HA (lane 9) and HA antibody coimmunoprecipitated
p50-HA in a complex with p65/GST (lane 12). These results
indicate that RAG-1 and hSRP1 interact specifically in mam-
malian as well as in yeast cells.
Mapping of SRP1 and RAG-1 Interacin Regions. The
regions in hSRP1 and RAG-1 that are involved in SRP1-
RAG-1 interaction were mapped by deletion analysis. A
detailed deletional analysis ofhSRPi (Fig. 3A) showed that the
area of hSRPi important for its interaction with RAG-1 is
located in the region of the protein containing the internal
repeats. The data also showed that the N- and C-terminal
domains of SRP1 were not essential for its interaction with
- 1 0 K
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FiG. 3. Mapping the interacting regions between RAG-1 and
hSRP1. (A) Mapping the hSRPi region that interacts with RAG-1.
Deletion constructs of hSRP1 were analyzed by their ability to
interact with RAG-1 by using the yeast two-hybrid system. Sche-
matic representation of the deletion constructs is shown. SRP1
repeats are indicated (boxes 1-8). Numbers on left indicate amino
acid region contained in each construct. Column on right shows the
constructs that scored positive (+) or negative (-). (B) Mapping the
RAG-1 region that interacts with hSRP1. Deletion constructs of
RAG-1 were analyzed by their ability to interact with hSRP1.
Schematic representation of the deletion constructs is shown. Zinc
finger domain is indicated by a solid bar.
RAG-1. A construct containing only the repeats 4, 5, 6, and 7
(amino acids 245-437) was still able to interact with RAG-1.
The additional deletion of the repeat 4 rendered the construct
(amino acids 289-437) unable to interact with RAG-1. Inter-
estingiy, addition of the C-terminal region gave rise to a
construct (amino acids 289-538) with the ability to interact
with RAG-1. Constructs containing repeats 7 and 8 and the
C-terminal region (amino acids 382-538) or the N-terminal
region and repeats 1, 2, 3, and 4 (amino acids 50-288) were
unable to interact with RAG-1. These results indicate that a
region containing at least four repeats (repeats 4, 5, 6, and 7)
is required for the interaction of hSRPi with RAG-1 and that
flanking sequences (the C-terminal region) are capable of
influencing this interaction.
A similar analysis of the protein region of RAG-1 involved
in the interaction with hSRPi showed that the N-terminal
region ofRAG-1 (amino acids 1-288) was sufficient for a stable
interaction with hSRP1, while no interaction was observed
between RAG-1 constructs containing most of the protein
(amino acids 330-1040) but lacking the N-terminal region.
Thus, amino acids 1-288, not containing the zinc finger,
contain the RAG-1 region responsible for interacting with
hSRP1.
DISCUSSION
We used the two-hybrid system modified by Brent and
colleagues (15) to identify proteins that interact with RAG-1.
One of the identified genes corresponded to the human
homologue of the previously cloned yeast protein SRPi. We
found that hSRP1 was able to interact with RAG-1 in yeast as
well as in mammalian cells. The yeast SRP1-i mutation is an
allele-specific dominant suppressor of a temperature-
sensitive mutation in the zinc binding domain of the A190
subunit of Saccharomyces cerevisiae RNA polymerase I.
SRP1 also suppressed a temperature-sensitive mutation in
the zinc binding domain of the polymerase I A135 subunit.
Previous studies have indicated that SRP1 is localized mainly
in certain regions of the nuclear periphery, probably in close
association with the nuclear envelope (16).
We used the truncated hSRP cDNA obtained from the
yeast two-hybrid system to clone a cDNA encoding a full-
length mSRP1 from a mouse cDNA library. A 3.9-kbp cDNA
was identified that encodes a full-length mSRP1. The mSRP1
showed 48% identity with yeast SRP1 and both shared a
similar structure. Three domains could be recognized: the N-
and C-terminal domains, which are very hydrophilic ones
poorly homologous between yeast and mouse, and a central
region containing eight degenerate repeats, which shows
more homology between mouse and yeast. Both m- and
hSRP1 are very conserved; comparison of both proteins
starting from Val-50 in the hSRP1 shows 97% identity. The
high conservation between mSRP1, hSRP1, and yeast SRP1
proteins is probably a good indication of the protein's im-
portant role in nuclear function. SRP1 was shown to be an
essential gene in yeast because disruption of this gene was
lethal.
We mapped the regions on hSRP1 and RAG-1 required for
their interaction. The minimal interaction region of hSRP1
seems to involve four repeats (repeats 4, 5, 6, and 7 or 5, 6,
7, and 8). This repeat, known as an arm motif and recently
found in other proteins, has also been shown to participate in
the interaction between the tumor suppressor adenomatous
polyposis coli and (3-catenin (22, 23). Thus, the suggestion
that this repeat is able to mediate specific protein-protein
interactions (18) is further supported by our work. The
four-repeat region of SRP1 responsible for interacting with
RAG-1 is located between amino acids 245 and 437 and is
therefore downstream of Pro-219, the amino acid altered in
the SRPi-i suppressor mutant ofRNA polymerase I. Genetic
evidence suggested that SRP1 and the two subunits A190 and
A135 of RNA polymerase I could interact directly through
the zinc finger present in both polymerase I subunits, mainly
because all the polymerase I temperature-sensitive mutants
that were suppressed by SRPi-i mutant (proline to glutamine
at position 219) were located in the zinc finger domain ofboth
polymerase I subunits (16). We thought that perhaps the zinc
finger domain ofRAG-1 present at the N terminus ofRAG-1
protein (between amino acids 290 and 328) might contain the
region responsible for interacting with hSRPl. However,
deletion analysis of RAG-1 protein showed that the RAG-1
region interacting with hSRP1 is located outside the zinc
finger domain, in the N-terminal region of RAG-1 between
amino acids 1 and 288. Thus, the interaction between RAG-1
and hSRP1 appears to occur through a different region from
that which might have been predicted based on the interac-
tion between polymerase I and SRP1. Since there is no direct
evidence for interaction between polymerase I and SRP1, it
is possible that they interact through other proteins. Alter-
natively, the temperature-sensitive mutation in both poly-
merase I subunits and the SRPi-i suppressor could alter
protein structure and the interaction may occur through
different regions of the two proteins (16). The evidence of a
link between RAG-1 and hSRP1 and between polymerase I
and SRP1 suggests that SRP1 may play an important role in
allowing critical nuclear reactions such as recombination and
transcription to become localized to the nuclear envelope, a
A
50-538
B
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localization that might bring together all the essential com-
ponents involved in these complex processes.
The analysis of deletion mutants of RAG-1 clearly showed
that RAG-1 interacted with hSRPi through a region con-
tained between amino acids 1 and 288. However, previous
studies indicated that the region of RAG-1 between amino
acids 1 and 384 was dispensable for the recombination of
exogenous plasmid substrates. Deletion of this complete
region decreased by 50% the recombination activity of the
protein (24, 25). This suggests that the conditions and re-
quirements for the recombination ofendogenous locus versus
exogenous substrates may be markedly different.
During recombination of exogenous substrates, the se-
quences to recombine are present at high concentration and
the recombination signal sequences are in very close prox-
imity. The situation is very different during recombination of
the endogenous locus, where the recombination signal se-
quences are kilobases apart from each other. Thus, even
when the region of RAG-1 that interacts with hSRPi appears
to have a small effect on the recombination activity of an
exogenous substrate, the role of this region in recombination
of endogenous genes may be far more relevant and remains
to be studied. In the context of endogenous recombination,
the interaction of RAG-1 with molecules located in the
nuclear envelope could provide the anchoring activity re-
quired to localize and perhaps start the formation of a
recombination-competent complex.
Important nuclear reactions such as replication and tran-
scription have been suggested and recently shown to occur in
specific regions of the nucleus. They seem to localize to the
nuclear matrix, forming large complexes known as replica-
tion and transcription factories. The factors involved in
replication as well as transcription are anchored in a solid
matrix and it has been shown that DNA moves through this
complex (26, 27). One might envision an analogous situation
for V(D)J recombination where recombination of endoge-
nous loci might normally require the association of the
recombination machinery to the nuclear envelope, perhaps
through interaction of RAG-1 with hSRPi. Localization of
both RAG-1 and RAG-2 to the nuclear periphery has been
observed in early thymocytes (E. Spanopoulou and D.B.,
unpublished data).
Note Added In Proof. Since this paper was submitted for publication,
an article by Cuomo et al. (28) describing a similar observation was
published.
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